Abstract
Background:
The optimal treatment of very elderly patients with ST elevation myocardial infarction (STEMI) is not yet defined. The aim of this study is to present the feasibility and safety of primary percutaneous coronary interventions (PCI) in nonagenarians.
Methods:
A retrospective analysis of all patients who underwent primary PCI due to STEMI between 2004 and 2008 was performed. Patients age 90 years or older at the time of the procedure were identified and studied.
Results:
Twenty‐two patients fulfilled the study criteria (median age 92 years; range, 90–97 years; 50% women). The procedural success rate was 82%. Bare metal stent implantation was performed in 82% of the procedures, whereas only balloon angioplasty was performed on the rest of them. One patient experienced a minor bleeding complication. Procedural mortality was 9% (2 out of 22 patients), and it was due to “no flow” phenomenon in both patients. In‐hospital mortality was 27% (6/22 patients) and 30‐day mortality was 32% (7/22 patients). All 3 patients with Killip class III–IV on admission died within 30 days compared with 4 of the 19 patients with Killip class I–II (P = 0.023). Furthermore, of 11 patients with anterior infarction, 7 died within 30 days compared with none of the 11 patients with infarction of other location (P = 0.004).
Conclusions:
Although primary PCI is feasible in patients 90 years or older suffering from STEMI, the short‐term mortality rate is high especially in patients with anterior infarct location and/or severely depressed myocardial function. Copyright © 2010 Wiley Periodicals, Inc.
Full Text
The Full Text of this article is available as a PDF (140.1 KB).
References
- 1. Gillum BS, Graves EJ, Wood E. National hospital discharge survey. Vital Health Stat 13 1998; 133: i–v, 1–51. [PubMed] [Google Scholar]
- 2. White HD. Thrombolytic therapy in the elderly. Lancet 2000; 356: 2028–2030. [DOI] [PubMed] [Google Scholar]
- 3. van't Hof AW, Liem A, Suryapranata H, et al. Angiographic assessment of myocardial reperfusion in patients treated with primary angioplasty for acute myocardial infarction: myocardial blush grade. Myocardial Infarction Study Group. Circulation 1998; 97: 2302–2306. [DOI] [PubMed] [Google Scholar]
- 4. Burn TR, Klima M, Teasdale TA, et al. Morphometry of the aging heart. Mod Pathol 1990; 3: 336–342. [PubMed] [Google Scholar]
- 5. Nixon JV, Hallmark H, Page K, Raven PR, Michell JH. Ventricular performance in human heart aged 61 to 73 years. Am J Cardiol 1985; 56: 932–937. [DOI] [PubMed] [Google Scholar]
- 6. Ornato JP, Pederdy MA, Tadler SC, et al. Factors associated with the occurrence of cardiac arrest during hospitalization for acute myocardial infarction in the Second National Registry of Myocardial infarction in the US. Resuscitation 2001; 48: 117–123. [DOI] [PubMed] [Google Scholar]
- 7. Bueno H, Martinez‐Selles M, Perez‐David E, et al. Effect of thrombolytic therapy on the risk of cardiac rupture and mortality in older patients with first acute myocardial infarction. Eur Heart J 2005; 26: 1705–1711. [DOI] [PubMed] [Google Scholar]
- 8. Alexander KP, Newby K, Armstrong PW, et al. Acute coronary syndromes in the elderly, Part II. ST‐segment elevation myocardial infarction. Circulation 2007; 115: 2570–2589. [DOI] [PubMed] [Google Scholar]
- 9. Briton A, Mckee M, Black N, et al. Threats to applicability of randomized trials: exclusions and selective participation. J Health Serv Res Policy 1999; 4: 112–121. [DOI] [PubMed] [Google Scholar]
- 10. Lee PY, Alexander KP, Hammil BG, et al. Presentation of elderly persons and women in published randomized trials of acute coronary syndromes. JAMA 2001; 286: 708–713. [DOI] [PubMed] [Google Scholar]
- 11. Boucher JM, Racine J, Thanh TH, et al.; Quebec Acute Coronary Care Working Group. Age‐related differences in in‐hospital mortality and the use of thrombolytic therapy for acute myocardial infarction. CMAJ 2001; 164: 1285–1290. [PMC free article] [PubMed] [Google Scholar]
- 12. Berger AK, Radford MJ, Wang Y, et al. Thrombolytic therapy in older patients. J Am Coll Cardiol 2000; 36: 366–374. [DOI] [PubMed] [Google Scholar]
- 13. Hovanesyan A, Rich MW. Outcomes of acute myocardial infarction in nonagenarians. Am J Cardiol 2008; 101: 1379–1383. [DOI] [PubMed] [Google Scholar]
- 14. Stone GW, Grines CL, Browne KF, et al. Predictors of in‐hospital and 6‐month outcome after acute myocardial infarction in the reperfusion era: the Primary Angioplasty in Myocardial Infarction (PAMI) trial. J Am Coll Cardiol 1995; 25: 370–377. [DOI] [PubMed] [Google Scholar]
- 15.The Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndromes (GUSTO IIb) Angioplasty Substudy Investigators. A clinical trial comparing primary coronary angioplasty with tissue plasminogen activator for acute myocardial infarction. N Engl J Med 1997; 336: 1621–1628. [DOI] [PubMed] [Google Scholar]
- 16. Andersen HR, Nielsen TT, Rasmunssen K, et al; DANAMI‐2 Investigators. A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction. N Engl J Med 2003; 349: 733–742. [DOI] [PubMed] [Google Scholar]
- 17. Goldenberg I, Matetzky S, Halkin A, et al. Primary angioplasty with routine stenting compared with fibrinolytic therapy in elderly patients with acute myocardial infarction. Am Heart J 2003; 145: 862–867. [DOI] [PubMed] [Google Scholar]
- 18. de Boer MJ, Ottervanger JP, van't Hof AW, et al.; Zwolle Myocardial Infarction Study Group. Reperfusion therapy in elderly patients with acute myocardial infarction: a randomized comparison of primary angioplasty and thrombolytic therapy. J Am Coll Cardiol 2002; 39: 1723–1728. [DOI] [PubMed] [Google Scholar]
- 19. Antoniucci D, Valenti R, Santoro GM, et al. Systematic primary angioplasty in octogenarians and older patients. Am Heart J 1999; 138: 670–674. [DOI] [PubMed] [Google Scholar]
- 20. Valente S, Lazzeri C, Salvadori C, et al. Effectiveness and safety of routine primary angioplasty in patients aged > or = 85 years with acute myocardial infarction. Circ J 2008; 72: 67–70. [DOI] [PubMed] [Google Scholar]
- 21. Hovanesyan A, Rich MW. Outcomes of acute myocardial infarction in nonagenarians. Am J Cardiol 2009; 101: 1379–1383. [DOI] [PubMed] [Google Scholar]
- 22. Stone GW, Grines CL, Cox DA, et al.; Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) Investigators. Comparison of angioplasty with stenting, with or without abciximad in acute myocardial infarction. N Engl J Med 2002; 346: 957–966. [DOI] [PubMed] [Google Scholar]
- 23. Stone GW, Witzenbichler B, Guagliumi G, et al; HORIZONS‐AMI Trial Investigators. Bivalirudin during primary PCI in acute myocardial infarction. N Engl J Med 2008; 358: 2218–2230. [DOI] [PubMed] [Google Scholar]